As of 2025-07-15, the Fair Value of Bolt Biotherapeutics Inc (BOLT) is -172.76 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.96 USD, the upside of Bolt Biotherapeutics Inc is -2,998.67%.
With the market price of 5.96 USD and our fair value calculation, Bolt Biotherapeutics Inc (BOLT) is not a good investment. Investing in BOLT stocks now will result in a potential loss of 2,998.67%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -60.73 | -98.59 | -88.10 | -69.20 | -63.12 | -75.95 |
| YoY growth | -99.18% | -62.34% | 10.64% | 21.46% | 8.79% | -24.13% |
| Market Cap (mil) | 10.93 |
| P/E | |
| Forward P/E |
| EPS | -34.55 |
| Avg earnings growth rate | -24.13% |
| TTM earnings | -63.35 |